Specialized Peptides / Subcutaneous
Adipotide
Also known as FTPP, Prohibitin-TP01
An experimental peptidomimetic that targets and destroys fat tissue blood supply through a targeted proapoptotic peptide. Causes fat cell death by cutting off blood supply to adipose tissue.
What is Adipotide used for? Research has focused on reduces adipose tissue mass; targets visceral fat deposits; induces selective fat cell apoptosis.
Compare with other peptides studied forfat loss,recovery and healing
Adipotide injection at a glance
Figures from the published research literature. Research use only.
- Dose range
- 0.5-1 mg
- Route
- Subcutaneous
How often, when, and the dosing notes are in the dosing reference further down.
Work out your units in the free calculatorBeginner basics
Plain-English guide to Adipotide
- What it does
- This experimental peptide works by cutting off the blood supply to fat cells, which causes them to die and shrink. Researchers study it because it targets fat tissue directly, especially deep belly fat, and may help improve how the body processes energy.
- Typical dose
- Research typically uses 0.5-1 mg once daily, injected under the skin. Important note: this is based on animal studies only-human dosing is completely unknown.
- When to inject
- No specific time requirement. Inject once daily at whatever time is convenient for you.
- Storage
- Keep the dry powder in the freezer at -20°C. Once you mix it with liquid, store it in the refrigerator between 2-8°C and keep it away from direct light.
- Beginner tip
- This peptide is still experimental with documented safety concerns and has never been tested in humans-understand the significant risks before using, and consider starting at the lower end of the dose range if you proceed.
Research status
- Evidence grade D
- Theoretical or in-vitro only, with no meaningful independent human evidence.
- Research only
- No regulatory approval in any major jurisdiction. Research use only.
Early Research
For research purposes only. Not approved for human use. Not medical advice.
Research areas
- Reduces adipose tissue mass
- Targets visceral fat deposits
- Induces selective fat cell apoptosis
- May improve metabolic markers
Side effects
| Effect | How often | Severity |
|---|---|---|
| Acute kidney injuryDocumented in preclinical studies at therapeutic doses. Manifests as elevated serum creatinine and blood urea nitrogen. Mechanism may involve vascular disruption in renal tissue or direct endothelial toxicity. Requires immediate medical evaluation and discontinuation. | Common | Serious |
| HepatotoxicityElevated liver enzymes (ALT, AST) observed in animal studies. Potential mechanism involves off-target vascular effects in hepatic tissue. Requires liver function monitoring and medical evaluation. | Common | Serious |
| Injection site reactionsLocal erythema, induration, or mild pain at injection site. Typically resolves within 24-48 hours. Rotate injection sites to minimize recurrence. | Uncommon | Mild |
| FatigueMay occur due to rapid metabolic changes or systemic effects. Usually mild and self-resolving. | Uncommon | Mild |
| NauseaReported in some preclinical studies. Typically mild and transient. | Uncommon | Mild |
| Vascular complicationsPotential for off-target vascular effects in tissues other than adipose tissue. Risk of thrombosis, hemorrhage, or ischemic injury to vital organs. Requires immediate medical attention. | Rare | Serious |
| CoagulopathyVascular disruption may trigger abnormal clotting. Requires hematologic monitoring and medical evaluation. | Uncommon | Serious |
Dosing reference
Dose scale from the research
- Starting
- 0.5 mg
- Upper end
- 1 mg
| Parameter | Value |
|---|---|
| Dose range | 0.5-1 mg |
Frequency, timing and route are for members | |
Checked October 2026
Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution guide
- Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
- Do not shake the vial vigorously; gentle swirling prevents peptide degradation
- Discard immediately if the solution appears cloudy, discolored, or contains visible particles
- Use within 30 days of reconstitution when stored at 2-8°C
- Do not freeze the reconstituted solution; freezing may denature the peptide
- Use the PeptideVolt reconstitution calculator for your exact concentration
Worked example
With 5 mg in the vial, the water you add changes the draw. Mixed with 1 mL that is 5,000 mcg per mL, so on a U-100 syringe 0.5 mg is 10 units and 1 mg is 20 units. Mixed with 2 mL it is 2,500 mcg per mL, so 0.5 mg is 20 units and 1 mg is 40 units.
Storage and stability
Store lyophilized peptide at -20°C. Refrigerate after reconstitution (2-8°C). Protect from light.
Molecular and pharmacological data
Adipotide is a peptidomimetic that targets the vasculature of adipose tissue through a proapoptotic mechanism. The peptide binds to integrin receptors on endothelial cells within fat tissue blood vessels, triggering apoptosis (programmed cell death) of these vascular cells. This vascular disruption cuts off blood supply to adipocytes, leading to selective fat cell death and reduction of adipose tissue mass.
Keep a log of your Adipotide research
Free account. No credit card required.
Recent research
All results on PubMedSource: PubMed / NCBI. Updated daily. Articles are listed for research reference only.
Research citations
3 sources
Kolonin MG, et al. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 10(6):625-32. PMID: 15133506
Zaragosi LE, et al. (2010). Activin A plays a critical role in proliferation and differentiation of human adipose progenitors. J Cell Physiol. 224(1):178-86. PMID: 20232316
Rupnick MA, et al. (2002). Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA. 99(16):10730-5. PMID: 12149466
Related: Specialized Peptides
All Specialized Peptides peptides- ApigeninA flavonoid with senolytic and anti-inflammatory properties used in cellular rej
- Calcitonin Gene-Related Peptide (CGRP) AntagonistsPeptide antagonists targeting CGRP receptors to reduce migraine frequency and pa
- DermorphinA 7-amino acid opioid peptide derived from amphibian skin that binds mu-opioid r
Browse the research library
147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.
View all peptidesStay updated on Adipotide research
A weekly digest of new peptide research, stack guides and site updates.
Research use only. All content on this page is provided for informational and educational purposes related to scientific research. Adipotide is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.